Sergio Ferrari

Sergio Ferrari

Auto-generated profile, based on publicly available information

Sergio Ferrari

Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy

Research Focus & Metrics

Academic Career Length

50Years (1977-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2007 in Cancer Research
Verified
Journal Article
Closed access
PDF file
Pier Paolo PiccalugaPier Paolo Piccaluga
Pier Paolo Piccaluga
CAClaudio Agostinelli
Claudio Agostinelli
ACAndrea Califano
Andrea Califano
Antonino CarboneAntonino Carbone
Antonino Carbone
LFLuca Fantoni
Luca Fantoni
SPStefano A. Pileri
Stefano A. Pileri
Angioimmunoblastic lymphoma (AILT) is the second most common subtype of peripheral T-cell lymphoma (PTCL) and is characterized by dismal prognosis. Thus far, only a few studies have dealt with its molecular pathogenesis. We performed gene expression profile (GEP) analysis of six AILT, six anaplastic large cell lymphomas (ALCL), 28 PTCL-unspecified (PTCL/U), and 20 samples of normal T lymphocytes (including CD4+, CD8+, and activated and resting subpopulations), aiming to (a) assess the relationship of AILT with other PTCLs, (b) establish the relationship between AILT and normal T-cell subsets, and (c) recognize the cellular programs deregulated in AILT possibly looking for novel potential therapeutic targets. First, we found that AILT and other PTCLs have rather similar GEP, possibly sharing common oncogenic pathways. Second, we found that AILTs are closer to activated CD4+, rather than to resting or CD8+ lymphocytes. Furthermore, we found that the molecular signature of follicular T helper cells was significantly overexpressed in AILT, reinforcing the idea that AILT may arise from such cellular counterpart. Finally, we identified several genes deregulated in AILT, including PDGFRA, REL, and VEGF. The expression of several molecules was then studied by immunohistochemistry on tissue microarrays containing 45 independent AILT cases. Notably, we found that the vascular endothelial growth factor (VEGF) was expressed not only by reactive cells, but also by neoplastic cells, and that nuclear factor-κB (NF-κB) activation is uncommon in AILT, as suggested by frequent exclusively cytoplasmic c-REL localization. Our study provides new relevant information on AILT biology and new candidates for possible therapeutic targets such as PDGFRA (platelet-derived growth factor α) and VEGF. [Cancer Res 2007;67(22):10703–10]

1 July 2006 in Blood
Verified
Journal Article
Closed access
PDF file
SRSergio Rutella
Sergio Rutella
GBGiuseppina Bonanno
Giuseppina Bonanno
APAnnabella Procoli
Annabella Procoli
AMAndrea Mariotti
Andrea Mariotti
DRDaniela G. de Ritis
Daniela G. de Ritis
RLRoberto M. Lemoli
Roberto M. Lemoli
Several hematopoietic growth factors, including interleukin-10 (IL-10) and transforming growth factor-β1 (TGF-β1), promote the differentiation of tolerogenic dendritic cells (DCs). Hepatocyte growth factor (HGF) is a pleiotropic cytokine whose effects on human DC differentiation and function have not been investigated. Monocytes cultured with HGF (HGFMo) differentiated into accessory cells with DC-like morphology, released low amounts of IL-12p70 and up-regulated IL-10 both at the mRNA and at the protein level. Upon activation with HGFMo, allogeneic CD4+CD25- T cells expressed the T regulatory (Treg)-associated transcription factor FoxP3, proliferated poorly, and released high levels of IL-10. Interestingly, blockade of surface immunoglobulin-like transcript 3 (ILT3) on HGFMo or neutralization of secreted IL-10 translated into partial restoration of T-cell proliferation. Secondary stimulation of HGFMo-primed CD4+ T cells with immunogenic DCs differentiated with granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4 from monocytes of the same donor resulted in measurable T-cell proliferation. HGFMo-primed CD4+ T cells significantly inhibited the proliferation of naive CD4+CD25- T cells in a cell-contact-dependent manner. Finally, DNA microarray analysis revealed a unique gene-expression profile of HGF-activated monocytes. Collectively, our findings point to a novel role for HGF in the regulation of monocyte/DC functions that might be exploited therapeutically. (Blood. 2006;108:218-227)

1 April 2007 in Developmental Biology
Verified
Journal Article
Closed access
SBStefano Biressi
Stefano Biressi
Enrico TagliaficoEnrico Tagliafico
Enrico Tagliafico
GLGiuseppe Lamorte
Giuseppe Lamorte
SMStefania Monteverde
Stefania Monteverde
ETelena tenedini
elena tenedini
GCGiulio Cossu
Giulio Cossu

1 May 1993 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
MLMario Luppi
Mario Luppi
Roberto MarascaRoberto Marasca
Roberto Marasca
PBPatrizia BAROZZI
Patrizia BAROZZI
SFSergio Ferrari
Sergio Ferrari
LCLuca Ceccherini‐Nelli
Luca Ceccherini‐Nelli
GTGiuseppe Torelli
Giuseppe Torelli

1 July 1994 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
Carlo PincelliCarlo Pincelli
Carlo Pincelli
CSCinzia Sevignani
Cinzia Sevignani
RMRossella Manfredini
Rossella Manfredini
AGAlexis Grande
Alexis Grande
FFFabrizio Fantini
Fabrizio Fantini
AGAlberto Giannetti
Alberto Giannetti

25 September 2014 in Blood
Verified
Journal Article
Open access
PDF file
RNRuggiero Norfo
Ruggiero Norfo
RZRoberta Zini
Roberta Zini
VPValentina Pennucci
Valentina Pennucci
EBELISA BIANCHI
ELISA BIANCHI
SSSimona Salati
Simona Salati
RMRossella Manfredini
Rossella Manfredini
Key Points: Differential gene and miRNA expression analysis in PMF granulocytes identifies new biomarkers and putative therapeutic targets. Activation of the miR-155/JARID2 axis in PMF CD34+ cells results in overproduction of MK precursors.